Key Takeaways
- 01. Stem-cell therapy targets retinal cell loss:
RP involves degeneration of photoreceptors, and stem-cell treatments aim to replace or support damaged retinal cells. - 02. Treatment mechanisms include differentiation and support:
Therapies use stem cells differentiated into retinal pigment epithelium or photoreceptor cells, injected into the retina or vitreous. - 03. Some vision improvements have been reported:
Patients have shown better visual acuity, night vision, wider visual fields, and more stable peripheral vision after therapy. - 04. Costs in India are documented and comparatively lower:
They are generally much more affordable compared to many other countries, making India a preferred destination for advanced medical care. - 05. Therapy remains experimental and individual results vary:
Long-term safety and efficacy are not yet fully established, and outcomes depend on disease stage, patient health, and treatment protocol.
Retinitis Pigmentosa — Overview
Retinitis pigmentosa (RP) is a group of inherited retinal disorders that gradually damage the light-sensitive cells of the retina. This leads to progressive vision loss, beginning with difficulty seeing at night and eventually affecting peripheral and central vision over time.
Traditional management options aim to slow vision deterioration but cannot regenerate damaged photoreceptor cells. Stem cell therapy, however, introduces regenerative potential by restoring impaired retinal cells, improving retinal function, and supporting visual clarity.
At Viezec, our advanced regenerative medicine programs focus on protecting, repairing, and revitalizing retinal tissue using ethically sourced stem cells — designed to preserve and enhance long-term vision quality for RP patients.
How Stem Cells Help in Retinitis Pigmentosa (RP)
Retinitis pigmentosa (RP) is a group of inherited retinal disorders that gradually destroy the light-sensitive cells of the retina. Patients typically experience night blindness, tunnel vision, and progressive loss of peripheral and central sight, which may eventually lead to severe visual impairment or blindness. The slow degeneration significantly affects mobility and independence in daily life.
Stem cell therapy, especially with mesenchymal stem cells (MSCs), supports retinal repair by replacing or rejuvenating damaged photoreceptor and retinal pigment epithelial cells. MSCs secrete neuroprotective and anti-inflammatory molecules that enhance retinal cell survival, improve microcirculation, and slow disease progression—helping stabilize or restore visual function in RP patients.
Causes of Retinitis Pigmentosa
Retinitis pigmentosa (RP) is a group of inherited retinal disorders caused by progressive loss of photoreceptor cells, primarily the rods, which impairs night vision and peripheral sight. Multiple genetic, cellular, and environmental mechanisms interact to produce the characteristic degeneration of the retina seen in RP.
- Inherited gene mutations: Variants in dozens of genes that affect photoreceptor structure or function are the primary cause of RP.
- Mode of inheritance: Autosomal dominant, autosomal recessive, and X-linked patterns influence disease onset, severity, and family risk.
- Photoreceptor cell death: Dysfunctional rods (and later cones) undergo apoptosis, leading to progressive vision loss over years.
- Oxidative and metabolic stress: Impaired cellular metabolism and reactive oxygen species accelerate photoreceptor degeneration.
- Retinal pigment epithelium dysfunction: Defects in the RPE impair photoreceptor support, waste clearance, and nutrient transport to the retina.
- Modifier and environmental factors: Light exposure, systemic health, and other genetic modifiers can affect progression and symptom severity.
Early genetic diagnosis and monitoring help guide prognosis and emerging therapies. At Viezec, our regenerative medicine team evaluates underlying causes to design individualized strategies aimed at preserving retinal function and slowing decline.
Symptoms of Retinitis Pigmentosa (RP)
Retinitis pigmentosa is a group of inherited retinal disorders that gradually damage the light-sensitive cells of the eye. Symptoms typically begin with night vision problems and slowly progress to peripheral vision loss. Recognizing early signs helps in managing the condition and protecting remaining vision.
- ✅ Difficulty seeing in dim light or at night
- ✅ Gradual loss of peripheral (side) vision
- ✅ Tunnel vision—seeing only objects straight ahead
- ✅ Sensitivity to bright light or glare
- ✅ Slower adjustment of eyes when moving from light to dark environments
⚠️ Important: Consult an eye specialist if you experience night blindness, shrinking side vision, or increased glare sensitivity. Early detection allows timely interventions and helps slow further vision deterioration.
Diagnosis of Retinitis Pigmentosa
Accurate diagnosis of Retinitis Pigmentosa (RP) is essential for genetic counselling and preserving remaining vision. At Viezec, our team employs advanced retinal imaging and functional tests to assess photoreceptor health and map the progression of RP.
Standard Diagnostic Tests Include:
- Comprehensive Eye Examination: Full retinal inspection to identify bone-spicule pigmentation, optic disc changes, and peripheral retinal degeneration.
- Optical Coherence Tomography (OCT): High-resolution cross-sections to evaluate photoreceptor layer integrity and retinal thickness.
- Electroretinography (ERG): Measures retinal electrical responses to light and quantifies rod and cone function decline typical of RP.
- Visual Field Testing: Assesses peripheral field loss and scotomas to monitor disease progression and functional vision impact.
🩺 Clinical Credibility: All RP diagnostic evaluations at Viezec are performed under the guidance of retina specialists and ophthalmologists, following international best practices. This ensures precise staging, genetic investigation where appropriate, and careful planning before any regenerative therapy or intervention is considered.
Stem Cell Treatment for Retinitis Pigmentosa
How It Works
Stem cell therapy for retinitis pigmentosa (RP) focuses on preserving peripheral and central vision by targeting the progressive degeneration of photoreceptors and their supportive retinal environment. Transplanted cells—derived from mesenchymal stem cells (MSCs) or pluripotent cell lines—can provide trophic support, replace damaged retinal cells, and attenuate harmful inflammation. These cells release growth factors and neuroprotective cytokines that help stabilise surviving photoreceptors, enhance local metabolic support, and promote synaptic repair. In selected patients this combined protective and regenerative activity can slow the course of degeneration and create potential for modest visual improvement or improved night and peripheral vision function over time.
Procedure at Viezec
At Viezec, RP interventions follow a patient-centred protocol developed by retinal specialists and regenerative medicine experts. Every phase—from eligibility screening through rehabilitation—is carried out in accordance with international standards inside GMP-certified facilities to guarantee cell integrity, sterility, and traceability across the treatment pathway.
- Comprehensive retinal imaging and functional testing to determine candidacy
- Selection and collection of autologous or donor stem cell material
- Cell expansion, differentiation as needed, and strict GMP processing
- Targeted delivery via subretinal, intravitreal, or systemic routes based on disease pattern
- Post-treatment monitoring, vision therapy, and scheduled follow-up assessments
Expected Outcomes
Many patients experience stabilization of visual field loss and occasional measurable gains in functional vision, such as improved night vision, contrast sensitivity, or reading ability, typically observed within 3–6 months after therapy. While dramatic recovery of long-lost vision is uncommon—particularly in advanced RP—clinical experience indicates that regenerative approaches can reduce the pace of degeneration, preserve remaining photoreceptors, and enhance daily visual performance for a portion of treated individuals.
Disclaimer: Outcomes depend on disease stage, genetic subtype of RP, patient age, and prior treatments. All procedures at Viezec are conducted under specialist medical supervision and are intended to complement established retinal care rather than replace it.
Retinitis Pigmentosa (RP) Treatment
At Viezec, our regenerative cell therapy approach for Retinitis Pigmentosa focuses on slowing degeneration and supporting photoreceptor function through safe, science-backed methods and potential visual stabilization. All cellular materials are prepared in GMP-certified laboratories that follow ISO standards, preserving purity and biological integrity before administration.
Treatments are performed under specialist ophthalmologic supervision using targeted intraocular delivery procedures with guidance. The protocol is individualized to the patient’s retinal status and overall health, enhancing cell survival, retinal repair, minimizing procedural discomfort while supporting functional outcomes.
👁️ Our Safety & Quality Commitments Include:
- GMP, ISO, and NABL certified laboratory environments
- Ethically sourced — no embryo-derived or fetal cells used
- Full sterility and infection control throughout all procedures
- Ongoing ophthalmologic evaluation and post-therapy care
Improvements & Results
Based on patient follow-ups at Viezec, many individuals treated for retinitis pigmentosa (RP) have reported measurable gains in functional vision — especially improvements in mobility, contrast detection, and ability to perform daily tasks in low light. Our multidisciplinary team monitors visual function through scheduled ophthalmic exams to ensure changes are safe and sustained.
Improved Mobility & Orientation
A substantial number of patients experienced better navigation in familiar environments and fewer obstacles during evening hours within 3–6 months after targeted interventions. Learn more about RP functional outcomes.
Enhanced Contrast & Low-Light Function
Patients commonly report improved ability to detect edges, steps, and faces in dim lighting, with better contrast sensitivity that supports everyday activities like walking and reading large print.
Stabilized Progression & Support
Ongoing monitoring demonstrates that many patients show slowed decline in peripheral field loss and sustained functional stability on follow-up assessments when combined with rehabilitative support.
Patient Experiences
“After treatment I feel more confident moving around at dusk — I no longer bump into furniture as often and can spot curbs earlier.”
– Patient from Pune, India
“The combination of therapy and low-vision strategies improved my contrast perception — I read larger headlines faster and feel steadier in low light.”
– Patient from Dubai
Frequently Asked Questions
What is stem cell treatment for Retinitis Pigmentosa?
Stem cell treatment for Retinitis Pigmentosa involves using specialized cells to repair or replace damaged retinal cells, potentially slowing disease progression and improving visual function.
Who can benefit from this therapy?
Candidates include individuals diagnosed with Retinitis Pigmentosa at various stages, depending on the extent of retinal degeneration and overall eye health, assessed by a retina specialist.
How is stem cell therapy administered for eye conditions?
Stem cells are typically injected directly into the eye (intravitreal or subretinal injection) or delivered via minimally invasive procedures under strict clinical supervision to target retinal repair.
Is the treatment safe for all age groups?
When performed in certified clinics by experienced ophthalmologists, stem cell therapy is generally safe. Minor side effects may include temporary inflammation, redness, or mild discomfort in the treated eye.
How soon can patients expect to see improvements in vision?
Visual improvements may vary and are typically observed gradually over weeks to months, depending on disease severity, patient age, and individual response to therapy.
How many treatment sessions are usually required?
The number of sessions depends on the patient’s condition and therapeutic goals. Most patients may require 1–2 sessions, followed by regular monitoring to track retinal response.
Can stem cell therapy replace other eye treatments?
Stem cell therapy is usually a complementary approach alongside conventional treatments such as vitamin supplementation, retinal implants, or low-vision aids, rather than a complete replacement.
How can I schedule a consultation for stem cell therapy?
You can schedule a consultation by contacting our clinic via phone, email, or the appointment request form on our website. Our team will evaluate your retinal condition and provide a personalized treatment plan.
For more questions, visit our FAQs page or request an evaluation with our expert team.
How Much Does Stem Cell Therapy Cost for Retinitis Pigmentosa?
The cost of stem cell therapy for Retinitis Pigmentosa (RP) depends on the patient’s visual condition, degree of retinal degeneration, type of stem cells used (such as mesenchymal or retinal progenitor cells), number of sessions, and the clinic’s expertise. Since regenerative eye treatments are highly specialized, prices can vary widely across countries based on medical technology, regulatory approvals, and healthcare infrastructure. Below is a general cost comparison across major countries.
Cost Comparison: Select Countries
The table below highlights approximate costs for a full stem cell therapy program for Retinitis Pigmentosa, including cell preparation, injection procedures, pre-treatment evaluation, and follow-up consultations.
| Country | Average Cost (in USD) | Average Cost (in INR) |
|---|---|---|
| United States 🇺🇸 | $22,000 – $35,000 | ₹18,20,000 – ₹29,00,000 |
| United Kingdom 🇬🇧 | $16,000 – $25,000 | ₹13,20,000 – ₹20,60,000 |
| Germany 🇩🇪 | $18,000 – $28,000 | ₹14,80,000 – ₹23,00,000 |
| Singapore 🇸🇬 | $13,000 – $22,000 | ₹10,70,000 – ₹18,10,000 |
While treatment in the USA, UK, and Germany offers advanced technology and experienced specialists, the overall cost remains significantly higher due to operational and regulatory factors. Many international patients prefer India, where equivalent-quality care and medical expertise are available at a much more affordable rate.
The lower cost of stem cell therapy in India is primarily driven by reduced healthcare expenses, favorable exchange rates, and efficient clinical operations. Reputed Indian hospitals use certified stem cell labs, globally trained ophthalmologists, and internationally approved protocols to deliver safe and effective regenerative eye treatments.
Why Choose Viezec?
Viezec collaborates with leading regenerative medicine centers and ophthalmology specialists who deliver personalized stem cell therapy for Retinitis Pigmentosa. We ensure transparent pricing, ethical standards, and full support from consultation to post-treatment follow-up.
Get a Personalized Cost Estimate
Each patient’s eye condition and treatment goals are unique. Contact our medical consultants to receive a customized quotation and treatment roadmap for your Retinitis Pigmentosa therapy.
Mechanism of Action: How Stem Cells Support Retinal Repair in Retinitis Pigmentosa
Stem cell therapy for Retinitis Pigmentosa (RP) focuses on restoring and preserving the photoreceptor layer that progressively degenerates due to genetic or metabolic dysfunction. Instead of simply replacing dead retinal cells, stem cells serve as biological repair agents—secreting growth factors, cytokines, and neuroprotective molecules that help maintain surviving retinal tissue and slow further vision loss.
- Photoreceptor Preservation: Stem cells release neurotrophic factors that protect and nourish remaining rod and cone cells, delaying degeneration.
- Retinal Microenvironment Repair: They help rebuild supportive tissue and improve intercellular communication within the retinal structure.
- Anti-inflammatory and Immune Balance: Stem cells regulate immune responses that trigger retinal damage, minimizing inflammation and apoptosis.
- Enhanced Oxygenation and Nutrient Supply: By promoting angiogenic signaling, stem cells improve local circulation and metabolic support for retinal cells.
This holistic regenerative approach underscores the potential of mesenchymal stem cells (MSCs) in addressing both early and advanced stages of RP. At Viezec, each treatment adheres to strict clinical standards ensuring safety, therapeutic accuracy, and ethical compliance for every individual patient.
Retinitis Pigmentosa
At Viezec, our regenerative treatment programs for Retinitis Pigmentosa (RP) are designed to protect and restore damaged retinal cells using scientifically validated stem cell therapies and customized care protocols. Our goal is to help maintain visual function, improve retinal strength, and slow the progression of degeneration with advanced, evidence-based methods.
We emphasize ethical, research-backed results and transparency throughout every stage of treatment. With our specialized ophthalmology experts, accredited clinical partners, and structured follow-up support, patients receive care that adheres to international safety and quality standards.
Treatment Results
Patients undergoing stem cell therapy for Retinitis Pigmentosa (RP) at Viezec may observe meaningful improvements such as enhanced peripheral light perception, slower progression of night vision loss, and better functional mobility in daily environments. Outcomes vary with disease stage, genetic subtype, and retinal resilience.
Regular follow-ups using diagnostic tools like OCT, visual field testing, and electroretinography (ERG) let clinicians closely monitor retinal response and adjust care. While some patients report measurable gains in light sensitivity and orientation, individual recovery timelines differ and are tracked over months.
At Viezec, our goal is to provide advanced regenerative options; however, we do not promise specific results or a cure. Responses to stem cell therapy for RP depend on each patient’s biology and disease characteristics. As an evolving, research-driven approach, outcomes remain variable and cannot be guaranteed. Learn more about our approach to retinal regenerative treatment.
Testimonials
Diego M. – Buenos Aires, Argentina – January 2020 – ⭐⭐⭐⭐☆
“My night vision was almost gone. After Viezec’s stem cell therapy, I can see better in dim light and move around more independently.”
Hana K. – Seoul, South Korea – June 2020 – ⭐⭐⭐⭐⭐
“Retinitis Pigmentosa had made reading difficult. Post-treatment at Viezec, my central vision improved, and I enjoy studying again.”
Ali B. – Rabat, Morocco – December 2020 – ⭐⭐⭐⭐☆
“I struggled with shrinking visual fields. After Viezec’s therapy, my peripheral vision stabilized, and I can manage daily tasks with more ease.”
Sophie N. – Paris, France – February 2021 – ⭐⭐⭐⭐⭐
“I feared losing my sight completely. Stem cell therapy at Viezec slowed down my RP, and I now have clearer, sharper vision.”
Pedro C. – Mexico City, Mexico – September 2021 – ⭐⭐⭐⭐☆
“Before therapy, I needed constant assistance outdoors. After treatment, my visual clarity improved, and I walk independently again.”
Anna V. – Athens, Greece – March 2022 – ⭐⭐⭐⭐⭐
“RP made it hard to recognize faces. Following Viezec’s stem cell therapy, I can see expressions more clearly, which has improved my confidence.”
Omar S. – Amman, Jordan – October 2022 – ⭐⭐⭐⭐☆
“Tunnel vision restricted my activities. Post-treatment at Viezec, my eyesight feels brighter, and I participate more in daily life.”
Isabella R. – Rome, Italy – April 2023 – ⭐⭐⭐⭐⭐
“My vision loss had progressed for years. Viezec’s therapy slowed the decline, and I regained some functional sight for daily chores.”
George P. – Sydney, Australia – November 2023 – ⭐⭐⭐⭐☆
“I struggled to navigate at night due to RP. After stem cell therapy, my night vision improved, and I feel safer moving around.”
Fatima L. – Kuala Lumpur, Malaysia – May 2025 – ⭐⭐⭐⭐⭐
“Viezec’s stem cell therapy gave me back confidence. My visual field widened, and I can enjoy outdoor activities with my family again.”
Success Rates & Patient Outcomes
At Viezec, our dedication to preserving and restoring vision in individuals affected by Retinitis Pigmentosa (RP) is guided by evidence-based clinical monitoring and patient feedback. Every intervention is followed by a structured post-treatment program to evaluate retinal response, functional vision changes, and day-to-day visual performance.
The success rate of stem cell therapy for RP varies with genetic subtype, stage of degeneration, and commitment to rehabilitation. In clinical follow-ups, patients commonly report functional vision improvement in 65–80% of cases, including better light perception, contrast sensitivity, and endurance during daily activities.
Treatments are performed in GMP-certified laboratories and overseen by specialists in regenerative ophthalmology. This ensures ethical standards, robust safety protocols, and transparent outcome reporting so patients can make informed decisions about care.
80%
Reported Visual Function Gain
92%
Overall Patient Satisfaction
Treatment Disclaimer
The content on this page discusses Retinitis Pigmentosa (RP) and available therapeutic approaches solely for informational and educational purposes.
It is not intended to replace professional medical diagnosis, consultation, or management. Each individual’s eye condition, stage of degeneration, and treatment response are unique; the generalized insights shared here may not fully represent your specific situation.
Viezec provides medically guided services grounded in current retinal research, ophthalmologic expertise, and clinical standards, but we cannot guarantee restoration of vision or uniform outcomes. Treatment planning should always be undertaken with a qualified retina specialist who understands your diagnostic imaging and overall health background.
- What this page does: Offers insights into RP causes, progression patterns, and evidence-informed treatment options.
- What this page does not do: Replace individualized medical advice or substitute for an in-person retinal assessment.
- If your night vision or field of sight worsens: Schedule urgent evaluation with an ophthalmologist or visit an eye emergency unit.
For a personalized management plan, we recommend scheduling a detailed retinal evaluation. Our medical team reviews each case comprehensively before advising on any therapeutic pathway.
What to expect in a professional evaluation
- Thorough review of visual history, family background, and advanced retinal imaging tests.
- Explanation of evidence-based RP management options, realistic goals, and possible risks.
- Detailed consent process before initiating any medical or regenerative intervention.
Conclusion
Stem cell therapy for Retinitis Pigmentosa offers a ray of hope for patients seeking to preserve and restore vision through regenerative science. By focusing on repairing damaged retinal cells and enhancing visual function, this advanced treatment aims to slow disease progression and improve quality of life. At Viezec, we combine ethical medical practices, expert clinical teams, and world-class facilities to deliver safe and personalized care for every patient. With India becoming a global destination for stem cell-based therapies, individuals can access effective, research-driven solutions at affordable costs. To explore how Viezec can support your journey toward better vision, contact our medical consultants today for a personalized assessment.
We Also Offer Treatments For
Our Testimonials
Related Videos
Recent Blog Posts
4.8 average based on 654 reviews.